BCAX
Bicara Therapeutics Inc.
+0.45 (+2.05%)22.45USD165K成交股數1.5B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-10下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 14 · 3.5M · 3 |
| 其中 10b5-1 計畫賣出 | 14 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 5.5M |
| 近 180 天 淨額 | −5.5M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-08 | 09-10 | Cohlhepp Ryan | President, COO & Interim CEO | M 選擇權執行 | 17.5K | 3.79 | 66K | 199K | SEC |
| 2026-09-08 | 09-10 | Cohlhepp Ryan | President, COO & Interim CEO | S 公開市場賣出(10b5-1) | 3.4K | 23.43 | 81K | 182K | SEC |
| 2026-09-08 | 09-10 | Cohlhepp Ryan | President, COO & Interim CEO | S 公開市場賣出(10b5-1) | 14.1K | 22.77 | 320K | 185K | SEC |
| 2026-08-10 | 08-12 | Hyep Ivan | Chief Financial Officer | S 公開市場賣出(10b5-1) | 12.5K | 27.97 | 350K | 130K | SEC |
| 2026-08-10 | 08-12 | Cohlhepp Ryan | President and COO | S 公開市場賣出(10b5-1) | 18.8K | 27.98 | 525K | 182K | SEC |
| 2026-08-10 | 08-12 | Mazumdar Claire | Chief Executive Officer | S 公開市場賣出(10b5-1) | 10.0K | 27.98 | 280K | 362K | SEC |
| 2026-08-10 | 08-12 | Hyep Ivan | Chief Financial Officer | M 選擇權執行 | 12.5K | 3.79 | 47K | 142K | SEC |
| 2026-08-10 | 08-12 | Mazumdar Claire | Chief Executive Officer | M 選擇權執行 | 10.0K | 3.79 | 38K | 372K | SEC |
| 2026-08-10 | 08-12 | Cohlhepp Ryan | President and COO | M 選擇權執行 | 18.8K | 3.79 | 71K | 200K | SEC |
| 2026-07-10 | 07-14 | Mazumdar Claire | Chief Executive Officer | M 選擇權執行 | 10.0K | 3.79 | 38K | 372K | SEC |
| 2026-07-10 | 07-14 | Mazumdar Claire | Chief Executive Officer | S 公開市場賣出(10b5-1) | 28 | 29.68 | 831.04 | 362K | SEC |
| 2026-07-10 | 07-14 | Mazumdar Claire | Chief Executive Officer | S 公開市場賣出(10b5-1) | 10.0K | 28.42 | 283K | 362K | SEC |
| 2026-07-09 | 07-10 | Cohlhepp Ryan | President and COO | S 公開市場賣出(10b5-1) | 536 | 29.00 | 16K | 182K | SEC |
| 2026-07-08 | 07-10 | Cohlhepp Ryan | President and COO | S 公開市場賣出(10b5-1) | 4.3K | 29.80 | 128K | 183K | SEC |
| 2026-07-08 | 07-10 | Cohlhepp Ryan | President and COO | S 公開市場賣出(10b5-1) | 22.8K | 28.76 | 657K | 188K | SEC |
| 2026-07-08 | 07-10 | Hyep Ivan | Chief Financial Officer | S 公開市場賣出(10b5-1) | 4.4K | 29.82 | 132K | 131K | SEC |
| 2026-07-08 | 07-10 | Cohlhepp Ryan | President and COO | S 公開市場賣出(10b5-1) | 1.1K | 30.35 | 33K | 182K | SEC |
| 2026-07-08 | 07-10 | Cohlhepp Ryan | President and COO | M 選擇權執行 | 18.8K | 3.79 | 71K | 210K | SEC |
| 2026-07-08 | 07-10 | Hyep Ivan | Chief Financial Officer | S 公開市場賣出(10b5-1) | 830 | 30.31 | 25K | 130K | SEC |
| 2026-07-08 | 07-10 | Hyep Ivan | Chief Financial Officer | S 公開市場賣出(10b5-1) | 22.8K | 28.60 | 651K | 135K | SEC |
| 2026-07-08 | 07-10 | Hyep Ivan | Chief Financial Officer | M 選擇權執行 | 12.5K | 3.79 | 47K | 158K | SEC |
| 2026-05-21 | 05-26 | Hyep Ivan | Chief Financial Officer | M 選擇權執行 | 9.2K | 3.79 | 35K | 155K | SEC |
| 2026-05-21 | 05-26 | Hyep Ivan | Chief Financial Officer | S 公開市場賣出(10b5-1) | 9.2K | 20.42 | 188K | 145K | SEC |
| 2026-05-18 | 05-20 | Mazumdar Claire | Chief Executive Officer | M 選擇權執行 | 15.0K | 3.79 | 57K | 377K | SEC |
| 2026-05-18 | 05-20 | Mazumdar Claire | Chief Executive Officer | S 公開市場賣出(10b5-1) | 3.0K | 20.35 | 61K | 362K | SEC |
| 2026-05-18 | 05-20 | Mazumdar Claire | Chief Executive Officer | S 公開市場賣出(10b5-1) | 12.0K | 19.96 | 240K | 365K | SEC |
| 2026-05-15 | 05-18 | Cohlhepp Ryan | President and COO | S 公開市場賣出(10b5-1) | 4.5K | 20.29 | 91K | 192K | SEC |
| 2026-05-15 | 05-18 | Cohlhepp Ryan | President and COO | M 選擇權執行 | 8.0K | 3.79 | 30K | 204K | SEC |
| 2026-05-15 | 05-18 | Cohlhepp Ryan | President and COO | S 公開市場賣出(10b5-1) | 8.0K | 20.29 | 162K | 196K | SEC |
| 2026-04-27 | 04-28 | Raben David | Chief Medical Officer | S 公開市場賣出(10b5-1) | 5.5K | 22.88 | 126K | 55.3K | SEC |
| 2026-04-27 | 04-28 | Raben David | Chief Medical Officer | M 選擇權執行 | 5.5K | 3.79 | 21K | 60.8K | SEC |
| 2026-04-21 | 04-22 | Hyep Ivan | Chief Financial Officer | M 選擇權執行 | 9.2K | 3.79 | 35K | 155K | SEC |
| 2026-04-21 | 04-22 | Hyep Ivan | Chief Financial Officer | S 公開市場賣出(10b5-1) | 9.2K | 23.00 | 212K | 145K | SEC |
| 2026-04-20 | 04-20 | Mazumdar Claire | Chief Executive Officer | M 選擇權執行 | 15.0K | 3.79 | 57K | 377K | SEC |
| 2026-04-20 | 04-20 | Mazumdar Claire | Chief Executive Officer | S 公開市場賣出(10b5-1) | 15.0K | 23.61 | 354K | 362K | SEC |
| 2026-04-16 | 04-20 | Mazumdar Claire | Chief Executive Officer | M 選擇權執行 | 8.2K | 4.44 | 37K | 348K | SEC |
| 2026-04-16 | 04-20 | Mazumdar Claire | Chief Executive Officer | M 選擇權執行 | 7.1K | 5.45 | 39K | 362K | SEC |
| 2026-04-16 | 04-20 | Mazumdar Claire | Chief Executive Officer | M 選擇權執行 | 7.5K | 3.79 | 28K | 355K | SEC |
| 2026-04-15 | 04-17 | Cohlhepp Ryan | President and COO | M 選擇權執行 | 8.0K | 3.79 | 30K | 209K | SEC |
| 2026-04-15 | 04-17 | Cohlhepp Ryan | President and COO | S 公開市場賣出(10b5-1) | 4.5K | 23.01 | 104K | 196K | SEC |
| 2026-04-15 | 04-17 | Cohlhepp Ryan | President and COO | S 公開市場賣出(10b5-1) | 8.0K | 23.01 | 184K | 201K | SEC |
| 2026-03-25 | 03-26 | Raben David | Chief Medical Officer | S 公開市場賣出(10b5-1) | 5.5K | 18.95 | 104K | 55.3K | SEC |
| 2026-03-25 | 03-26 | Raben David | Chief Medical Officer | M 選擇權執行 | 5.5K | 3.79 | 21K | 60.8K | SEC |
| 2026-03-23 | 03-24 | Hyep Ivan | Chief Financial Officer | S 公開市場賣出(10b5-1) | 9.2K | 18.52 | 170K | 145K | SEC |
| 2026-03-23 | 03-24 | Hyep Ivan | Chief Financial Officer | M 選擇權執行 | 9.2K | 3.79 | 35K | 155K | SEC |
| 2026-03-20 | 03-20 | Mazumdar Claire | Chief Executive Officer | S 公開市場賣出(10b5-1) | 1.6K | 18.95 | 30K | 339K | SEC |
| 2026-03-20 | 03-20 | Mazumdar Claire | Chief Executive Officer | M 選擇權執行 | 1.6K | 3.79 | 6K | 341K | SEC |
| 2026-03-19 | 03-20 | Mazumdar Claire | Chief Executive Officer | M 選擇權執行 | 6.9K | 3.79 | 26K | 346K | SEC |
| 2026-03-19 | 03-20 | Mazumdar Claire | Chief Executive Officer | S 公開市場賣出(10b5-1) | 6.9K | 18.78 | 130K | 339K | SEC |
| 2026-03-18 | 03-20 | Mazumdar Claire | Chief Executive Officer | M 選擇權執行 | 6.5K | 3.79 | 25K | 346K | SEC |
| 2026-03-18 | 03-20 | Mazumdar Claire | Chief Executive Officer | S 公開市場賣出(10b5-1) | 6.5K | 18.84 | 122K | 339K | SEC |
| 2026-03-16 | 03-17 | Cohlhepp Ryan | President and COO | M 選擇權執行 | 8.0K | 3.79 | 30K | 213K | SEC |
| 2026-03-16 | 03-17 | Cohlhepp Ryan | President and COO | S 公開市場賣出(10b5-1) | 4.5K | 19.66 | 88K | 201K | SEC |
| 2026-03-16 | 03-17 | Cohlhepp Ryan | President and COO | S 公開市場賣出(10b5-1) | 8.0K | 19.66 | 157K | 205K | SEC |
| 2026-03-09 | 03-11 | Mazumdar Claire | Chief Executive Officer | S 公開市場賣出(10b5-1) | 36.8K | 19.17 | 705K | 339K | SEC |
| 2026-03-09 | 03-11 | Mazumdar Claire | Chief Executive Officer | M 選擇權執行 | 36.8K | 3.79 | 139K | 376K | SEC |
| 2026-03-06 | 03-06 | Mazumdar Claire | Chief Executive Officer | S 公開市場賣出(10b5-1) | 3.8K | 18.75 | 72K | 339K | SEC |
| 2026-03-06 | 03-06 | Mazumdar Claire | Chief Executive Officer | M 選擇權執行 | 3.8K | 3.79 | 14K | 343K | SEC |
| 2026-03-05 | 03-06 | Mazumdar Claire | Chief Executive Officer | S 公開市場賣出(10b5-1) | 1.8K | 18.74 | 33K | 339K | SEC |
| 2026-03-05 | 03-06 | Mazumdar Claire | Chief Executive Officer | M 選擇權執行 | 1.8K | 3.79 | 7K | 341K | SEC |
| 2026-03-04 | 03-06 | Mazumdar Claire | Chief Executive Officer | S 公開市場賣出(10b5-1) | 2.6K | 18.73 | 49K | 339K | SEC |
| 2026-03-04 | 03-06 | Mazumdar Claire | Chief Executive Officer | M 選擇權執行 | 2.6K | 3.79 | 10K | 342K | SEC |
| 2026-03-04 | 03-05 | Hyep Ivan | Chief Financial Officer | S 公開市場賣出(10b5-1) | 3.0K | 18.25 | 54K | 145K | SEC |
| 2026-03-04 | 03-05 | Hyep Ivan | Chief Financial Officer | M 選擇權執行 | 3.0K | 3.79 | 11K | 148K | SEC |
| 2026-03-04 | 03-05 | Raben David | Chief Medical Officer | M 選擇權執行 | 16.3K | 3.79 | 62K | 71.6K | SEC |
| 2026-03-04 | 03-05 | Raben David | Chief Medical Officer | S 公開市場賣出(10b5-1) | 16.3K | 18.52 | 302K | 55.3K | SEC |
| 2026-03-03 | 03-05 | Raben David | Chief Medical Officer | M 選擇權執行 | 200 | 3.79 | 758.00 | 55.5K | SEC |
| 2026-03-03 | 03-05 | Hyep Ivan | Chief Financial Officer | M 選擇權執行 | 7.3K | 3.79 | 28K | 153K | SEC |
| 2026-03-03 | 03-05 | Cohlhepp Ryan | President and COO | S 公開市場賣出(10b5-1) | 12.9K | 18.16 | 234K | 210K | SEC |
| 2026-03-03 | 03-05 | Cohlhepp Ryan | President and COO | M 選擇權執行 | 12.9K | 3.79 | 49K | 223K | SEC |
| 2026-03-03 | 03-05 | Raben David | Chief Medical Officer | S 公開市場賣出(10b5-1) | 200 | 18.45 | 4K | 55.3K | SEC |
| 2026-03-03 | 03-05 | Hyep Ivan | Chief Financial Officer | S 公開市場賣出(10b5-1) | 13.6K | 18.22 | 247K | 145K | SEC |
| 2026-03-03 | 03-05 | Hyep Ivan | Chief Financial Officer | M 選擇權執行 | 6.2K | 3.79 | 24K | 159K | SEC |
| 2026-03-03 | 03-05 | Cohlhepp Ryan | President and COO | S 公開市場賣出(10b5-1) | 4.5K | 18.16 | 82K | 205K | SEC |
| 2026-02-26 | 03-02 | RA CAPITAL MANAGEMENT, L.P. | Director,TenPercentOwner | P 公開市場買進 | 300K | 16.00 | 4.8M | 4.6M | SEC |
| 2026-02-26 | 03-02 | RA Capital Nexus Fund III, L.P. | Director | P 公開市場買進 | 300K | 16.00 | 4.8M | 4.6M | SEC |
| 2026-02-26 | 03-02 | Shah Rajeev M. | Director,TenPercentOwner | P 公開市場買進 | 300K | 16.00 | 4.8M | 4.6M | SEC |
| 2026-02-26 | 03-02 | Kolchinsky Peter | Director,TenPercentOwner | P 公開市場買進 | 300K | 16.00 | 4.8M | 4.6M | SEC |
| 2026-02-26 | 03-02 | RA Capital Healthcare Fund LP | Director,TenPercentOwner | P 公開市場買進 | 300K | 16.00 | 4.8M | 4.6M | SEC |
| 2026-02-25 | 02-27 | Cohlhepp Ryan | President and COO | M 選擇權執行 | 3.1K | 3.79 | 12K | 213K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 7.3M | 215M | 新進 | 新進 |
| Siren, L.L.C. | 5.6M | 166M | 新進 | 新進 |
| Vestal Point Capital, LP | 5.3M | 156M | 新進 | 新進 |
| Deep Track Capital, LP | 4.1M | 122M | 新進 | 新進 |
| BlackRock, Inc. | 3.8M | 114M | 新進 | 新進 |
| Jupiter Topco LLC | 3.2M | 94.0M | 新進 | 新進 |
| RED TREE MANAGEMENT, LLC | 3.2M | 93.9M | 新進 | 新進 |
| TPG GP A, LLC | 3.0M | 89.4M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.2M | 65.8M | 新進 | 新進 |
| STATE STREET CORP | 2.0M | 60.8M | 新進 | 新進 |
| FRANKLIN RESOURCES INC | 2.0M | 58.0M | 新進 | 新進 |
| FMR LLC | 1.9M | 56.2M | 新進 | 新進 |
| Omega Fund Management, LLC | 1.8M | 54.1M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.2M | 34.5M | 新進 | 新進 |
| JPMORGAN CHASE & CO | 1.0M | 29.8M | 新進 | 新進 |
| Jones Hill Capital LP | 893K | 26.5M | 新進 | 新進 |
| ACORN CAPITAL ADVISORS, LLC | 643K | 19.1M | 新進 | 新進 |
| Aisling Capital Management LP | 569K | 16.9M | 新進 | 新進 |
| Palo Alto Investors LP | 550K | 16.3M | 新進 | 新進 |
| Rock Springs Capital Management LP | 535K | 15.9M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 521K | 15.5M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 498K | 14.8M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 462K | 13.7M | 新進 | 新進 |
| NAN FUNG TRINITY (HK) LTD | 428K | 12.7M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 419K | 12.4M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 171 +26 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 171 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 69.8M · 100.0% |
| 合計季末市值 | 1.8B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 10.8M |
|---|---|
| 與上期比 | +3.6% |
| 佔流通股數 | 16.39% |
| 日均成交量 | 491K |
| 回補天數 | 22.1 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 10.8M | +3.6% | 16.39% | 491K | 22.1 |
| 2026-08-14 | 10.5M | +9.0% | 15.81% | 788K | 13.3 |
| 2026-07-31 | 9.6M | +3.0% | 14.50% | 470K | 20.4 |
| 2026-07-15 | 9.3M | -8.0% | 14.08% | 734K | 12.7 |
| 2026-06-30 | 10.1M | -0.4% | 15.30% | 1.4M | 7.3 |
| 2026-06-15 | 10.2M | +0.8% | 15.35% | 514K | 19.8 |
| 2026-05-29 | 10.1M | +2.4% | 15.24% | 448K | 22.5 |
| 2026-05-15 | 9.8M | +10.7% | 14.88% | 569K | 17.3 |
| 2026-04-30 | 8.9M | -4.6% | 13.44% | 417K | 21.4 |
| 2026-04-15 | 9.3M | -3.3% | 14.09% | 636K | 14.7 |
| 2026-03-31 | 9.6M | +3.0% | 14.57% | 585K | 16.5 |
| 2026-03-13 | 9.4M | +1.0% | 14.15% | 619K | 15.1 |
| 2026-02-27 | 9.3M | +5.2% | 14.01% | 626K | 14.8 |
| 2026-02-13 | 8.8M | -1.0% | 13.32% | 328K | 26.9 |
| 2026-01-30 | 8.9M | -0.1% | 13.45% | 412K | 21.6 |
| 2026-01-15 | 8.9M | -2.6% | 13.46% | 474K | 18.8 |
| 2025-12-31 | 9.1M | +14.1% | 13.83% | 609K | 15.0 |
| 2025-12-15 | 8.0M | +4.8% | 12.12% | 655K | 12.3 |
| 2025-11-28 | 7.7M | +6.0% | 11.57% | 754K | 10.2 |
| 2025-11-14 | 7.2M | +11.8% | 10.91% | 677K | 10.7 |
| 2025-10-31 | 6.5M | +13.7% | 9.76% | 804K | 8.0 |
| 2025-10-15 | 5.7M | +4.1% | 8.58% | 652K | 8.7 |
| 2025-09-30 | 5.5M | -3.7% | 8.25% | 693K | 7.9 |
| 2025-09-15 | 5.7M | +5.1% | 8.57% | 280K | 20.2 |
| 2025-08-29 | 5.4M | -1.3% | 8.15% | 277K | 19.5 |
| 2025-08-15 | 5.5M | -2.3% | 8.25% | 316K | 17.3 |